The ACVP-mediated enrichment of Akkermansia muciniphila, a mucin-degrading bacterium associated with improved gut barrier integrity and anti-inflammatory effects, aligns with its established role in mitigating metabolic syndrome and type 2 diabetes. This evidence concerns the gene MUC5AC and type 2 diabetes mellitus.